Robert Hart, Forbes Staff

Author's posts

Humidifiers Could Lower Covid-19 Infection Risks In Winter, Research Suggests

Dry conditions could mean a greater risk of catching coronavirus, according to recent research using a Japanese supercomputer.

America’s Pandemic Death Rate Is Far Higher Than Other Countries And It’s Not Coming Down

Controlled for population, more Americans are dying during the pandemic than in many other wealthy countries.

Man, 25, Is The First In The U.S. To Catch Covid-19 Twice, Second Time Worst That The First

The first confirmed case of reinfection in the U.S. raises further doubts about herd immunity.

Johnson & Johnson Halt All Covid-19 Vaccine Trials Over ‘Unexplained Illness’

The pause includes late-stage stage trials for the group’s single dose Covid-19 vaccine.

Only 50% Of Americans Are Willing To Get A Covid-19 Vaccine, Poll Shows

According to a Gallup poll, Americans’ readiness to get an FDA-approved Covid-19 vaccine plummeted a steep 11 points in late September from the previous month.

‘Extremely Robust’ Covid-19 Virus Reportedly Lasts 28 Days On Glass And Currency

A team of Australian scientists have found that the virus that causes Covid-19 can survive up to 10 days longer than flu on some surfaces, highlighting the importance of regular handwashing and cleaning.

While Trump Touts ‘Cure’ Made By Regeneron, Its CEO Is A Member Of Trump Golf Club

Trump received exclusive access to an experimental antibody therapy produced by Regeneron

Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic

This would allow other companies developing coronavirus vaccines to use Moderna’s technology.

EU Secures Up To 500,000 Remdesivir Treatment Courses Amid Global Shortages

After the U.S. bought almost all of the global supply of the antiviral drug, many European countries reported shortages amid a surge in coronavirus cases

Regeneron Seeks FDA Emergency Approval For Covid-19 Therapy Trump Calls A ‘Cure’

The company’s experimental antibody therapy — which was given to President Donald Trump Friday after he was diagnosed with Covid-19 — is still in clinical trials and not yet approved for wider use.